Citalopram, irinotecan hydrochloride recalled
April 5th 2011APP Pharmaceuticals Inc. in Schaumburg, Ill., recently recalled 5 lots of irinotecan hydrochloride injection, used to treat recurrent or progressive metastatic colorectal cancer. Greenstone LLC has recalled 1 lot of Citalopram, used to treat depression, because the bottles may contain finasteride.
Vimovo well tolerated by arthritis patients at risk for gastric ulcers
April 5th 2011Naproxen/esomeprazole magnesium (Vimovo, AstraZeneca and Pozen) 500/20-mg delayed-release tablets was generally well tolerated in osteoarthritis patients requiring daily NSAID therapy who were at risk for NSAID-associated ulcers, according to a study published in Current Medical Research & Opinion.
5α-reductase inhibitors in BPH linked with adverse sexual effects
April 5th 20115α-reductase inhibitors may cause persistent erectile dysfunction, depression, and loss of libido, even after discontinuing use, in men being treated for systems of benign prostatic hyperplasia and androgenetic alopecia, according to a literature review published in The Journal of Sexual Medicine.
Purdue offers Florida $1 million to create "pill mill" database
April 5th 2011While Purdue Pharma, the manufacturer of OxyContin, has offered the State of Florida $1 million for a pill mill database, the anticipated cost of sustaining the program may deter Florida Governor Rick Scott and other legislators from accepting the grant.
American Regent recalls Dexamethasone Sodium Phosphate Injection and Sodium Chloride Injection
March 31st 2011American Regent, a division of Luitpold Pharmaceuticals in Shirley, N.Y., recently recalled several lots of Dexamethasone Sodium Phosphate Injection and Sodium Chloride Injection because they may contain particulates.
Health & Wellness Conference focuses on whole-store approach
March 29th 2011The 2011 Health & Wellness Conference taking place April 3 to April 5 at the Omni Resort at ChampionsGate in Orlando, Fla., will give supermarket executives opportunities to collaborate with suppliers and service providers on ways to meet the wellness needs of consumers.
FDA takes aim at corporate executives to rein in pharma abuses
March 29th 2011FDA has a new target in its continuing efforts to clean up pharmaceutical industry abuses: individual corporate officials. The most recent targets are the vice president of quality and the vice president of operations for OTC Products at McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson.
Poison Prevention Week stresses dangers of Rx, OTC poisonings
March 24th 2011The American College of Emergency Physicians and the American Association of Poison Control Centers are raising awareness about the dangers of drug poisoning as part of Poison Prevention Week, which is taking place March 20 to 26.
Resistance testing should guide initial HIV treatment choice
March 22nd 2011A substantial portion of antiretroviral-naive patients are infected with transmitted drug-resistant HIV with 1 or more drug-resistant mutations, and they are much more likely to experience treatment failure, according to a European multicohort study published in The Lancet Infectious Disease.
Multiple factors influence willingness of elderly to take cardiovascular drugs
March 22nd 2011The willingness of the elderly to take medication for primary cardiovascular disease prevention is relatively insensitive to its benefit but highly sensitive to its adverse effects, according to a recent study in the Archives of Internal Medicine.